DUBLIN, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that management team members will present and meet with investors at three banking conferences this month:
Rodman & Renshaw Annual Global Investment Conference
Monday, September 9th at 12:30 pm ET
New York
Morgan Stanley Global Healthcare Conference
Wednesday, September 11th at 10:00 am ET
New York
Stifel Healthcare Conference 2013
Wednesday, September 11th at 10:20 am ET
Boston
Live webcasts of the presentations will be available in the Investor Events section of the Company's website, www.astx.com. The webcasts will be archived for 30 days.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.